SMALL DRUG MOLECULES

Brand Owner (click to sort) Address Description
CHEMILOGIC EMPRESS THERAPEUTICS, INC. 55 Cambridge Parkway, Suite 800E Cambridge MA 02142 Small drug molecules; small molecules; small molecules that are encoded in DNA related to human health and disease; biological and chemical agents for scientific and research use; chemical compounds; pharmaceutical preparations and therapeutics for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; drug development; drug development software platform featuring artificial intelligence and machine learning; software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical and genomic research; software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products; pharmaceutical and biotech research and development;
CHEMILOGICA EMPRESS THERAPEUTICS, INC. 55 Cambridge Parkway, Suite 800E Cambridge MA 02142 Small drug molecules; small molecules; small molecules that are encoded in DNA related to human health and disease; biological and chemical agents for scientific and research use; chemical compounds; pharmaceutical preparations and therapeutics for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; drug development; drug development software platform featuring artificial intelligence and machine learning; software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical and genomic research; software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products; pharmaceutical and biotech research and development;
CHEMILOGICAL EMPRESS THERAPEUTICS, INC. 55 Cambridge Parkway, Suite 800E Cambridge MA 02142 Small drug molecules; small molecules; small molecules that are encoded in DNA related to human health and disease; biological and chemical agents for scientific and research use; chemical compounds; pharmaceutical preparations and therapeutics for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; drug development; drug development software platform featuring artificial intelligence and machine learning; software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical and genomic research; software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products; pharmaceutical and biotech research and development;
CHEMILOGICS EMPRESS THERAPEUTICS, INC. 55 Cambridge Parkway, Suite 800E Cambridge MA 02142 Small drug molecules; small molecules; small molecules that are encoded in DNA related to human health and disease; biological and chemical agents for scientific and research use; chemical compounds; pharmaceutical preparations and therapeutics for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; drug development; drug development software platform featuring artificial intelligence and machine learning; software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical and genomic research; software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products; pharmaceutical and biotech research and development;
CHEMILOGIX EMPRESS THERAPEUTICS, INC. 55 Cambridge Parkway, Suite 800E Cambridge MA 02142 Small drug molecules; small molecules; small molecules that are encoded in DNA related to human health and disease; biological and chemical agents for scientific and research use; chemical compounds; pharmaceutical preparations and therapeutics for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; drug development; drug development software platform featuring artificial intelligence and machine learning; software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical and genomic research; software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products; pharmaceutical and biotech research and development;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Novel molecules of the multi-drug and toxin efflux (MATE) family of molecules, designated herein as mutant ferric reductase defective (FRD3) nucleic acid and protein molecules are disclosed. The FRD3 nucleic acid and protein molecules are useful as modulating agents in regulating metal homeostasis, e.g., iron homeostasis. The invention further describes transgenic plants in which expression of a FRD3 polypeptide of the invention is altered. Compositions containing FRD3 molecules and methods of using such molecules are also provided.